Research done by Dr. Jackleen Raafat Awadallah Hanna Phd of Medical Biochemistry Researcher at Medical Biochemistry Department National Research Center.

Slides:



Advertisements
Similar presentations
Relapse in Children with ALL By Dr Kaji Protocol for Acute Lymphoblastic Leukemia Relapse IN LANZKOWSKY.
Advertisements

TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Neel Bhalala (2009) Sofia Medical University. Background  Erythropoiesis-stimulating agents are man-made versions of a natural protein known as erythropoietin.
A Hematology Case Study about Leukemia by Sarah Wycoff
Acute Myelogenous Leukemia and its Impact on the Immune System
LEUKEMIA—HEMATOLOGY {S1}
Apoptosis By Dr Abiodun Mark .A.
The Story of Bcl-2 Linking cell apoptosis to tumor metastasis Crystal structure of Bcl-2 complex By Yaming Wang.
Targeted Therapies Against Lymphocyte Signaling Pathways in Childhood Leukemia Stuart S. Winter, MD Pediatric Hematology/Oncology The T. John Gribble Endowed.
Acute Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH.
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Armstrong et al, Nature Genetics 30, (2002)
When mammalian cells are subjected to stress signals, oxygen deficiency, radiation, DNA damage, or Chemo- therapeutic drugs, p53 is activated, leading.
LEUKEMIA. What Is It? Leukemia is a type of cancer that starts in the tissue that forms blood.
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Marty O’Neill II Carmen Banea
Flow Cytometric Abnormalities in Myelodysplastic Syndrome Raida Oudat,MD Consultant Hematopathologist at Princess Iman Research and Laboratory Sciences.
Apoptosis-related Diseases  Insufficient apoptosis  Excessive apoptosis  Coexistence of insufficient and excessive apoptosis.
Livin in Prognosis of Childhood ALL Livin- member of inhibitor of apoptosis proteins (IAP). – IAP- acts on effector and initiator caspases Function of.
MEDICAL TESTING Doctor requires information Patient sample collection
Cancer Uncontrolled cell growth. Cellular differentiation is the process by which a less specialized cell becomes a more specialized cell type. Occurs.
Acute Leukemia and the FLT3 Receptor B y: Betty Sa’ Mentor: Dr. Govind Bhagat Site: Columbia University Vanderbilt Clinic.
8.2 – Blood and Circulation Blood is considered a connective tissue because it links all cells and organs in the body Blood consists of a fluid portion.
Chronic Leukemias. CMLCML CLLCLL CML A clonal disease results from an acquired genetic change in a pluri-potential hemopoietic stem cell within the BM.
LIBYAN EXPERIENCE IN PEDIATRIC ACUTE MYELOID LEUKEMIA Fathia El Riani, Rasem Al Ajnef, Elham Sbita, Salem Zarroug Departement of pediatric hematology-oncology.
Is Cancer Really that Dangerous? Cause of Death Lifetime odds of dying Car Crash1 in 242 Drowning1 in 1,028 Plane Crash1 in 4,608 Lightning1 in 71,501.
Myeloproliferative Disorders (MPDs)
D EPARTMENT OF I MMUNOLOGY & H ISTOCOMPATIBILITY – U NIVERSITY OF T HESSALY TNFRSF13B/TACI and TNFRSF13C/BAFFR in B cell chronic lymphocytic leukemia.
Apoptosis in Cancer By: Karen Hutcherson Ryan Jenkins Angie Lam Jennie Zaborsky ISAT
Inhibition of PDCD6 Induces Cell Proliferation and Reduces Apoptosis in Human Epithelial Ovarian Cancer Cells Yan Huang, Xiaohua Wu Department of Gynecology,
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Leukemia Omidreza keshavarz Ahmad darvishi Nursing 86 Hormozgan university of medical sciences Bandarabbas faculty of nursing،midwifery and paramedical.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 25 Blood Cells and the Hematopoietic System.
Chapter 15.  Immunological tolerance is defined as unresponsiveness to an antigen that is induced by previous exposure to that antigen  Antigens that.
ONCOGENE AND ITS ROLE IN THE DEVELOPMENT OF LEUKAEMIA Nouf khaled al-Hajjar SUPERVISOR Dr.SAMINA HAQ.
Complete Blood Count (CBC)
Case report Sudden blastic transformation in patient with chronic myeloid leukemia treated with imatinib mesylate Mehrdad Payandeh,MD Hematology, Medical.
Paige Myers & Mahek Shah.  Cancer is a disease in which the DNA of cells becomes damaged or changed and the affected cells do not respond to apoptosis.
HAPLOIDENTICAL STEM CELL TRANSPLANT
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Acute lymphoblastic leukemia in children
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
MLAB Hematology Keri Brophy-Martinez Hematopoiesis.
Activation of T Lymphocytes
Blood Biochemistry BCH 577
Serum Vascular Endothelial Growth Factor-A Level Before and After Induction Therapy in Egyptian Children with Acute Lymphoblastic Leukemia Sayed.A. Fadel1.
Acute myeloid leukemia
CLINICAL PROGRESSION INTRODUCTION METHOD CONCLUSION REFERENCES
B-cell receptor signaling in chronic lymphocytic leukemia
Serum ceruloplasmin, copper, zinc levels and Cu/Zn ratio in malignancy
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
11 th lecture Chronic myeloid leukaemia By DR Fatehia Awny Faculty of Health Science Beirut Arab University
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Early T-Cell Precursor ALL in 5 Year Old Female
ENVL-GEOL, SUST and CHEM
17 Chapter 17: Chromosome 17 Nucleus 48,473 bp 882 aa RARA Cytoplasm
Case Study ….
Chronic Leukemia Kristine Krafts, M.D..
Stem Cells and Cellular Differentiation
Hairy cell Leukemia Case study.
Unit #6B – Clinical Laboratory Testing Basic Hematology
Bcl-2: A Matter of Life-or-Death
Death Becomes Us: Apoptosis and Carcinogenesis
Neoplastic disorder.
Lymphoma in Pediatrics 23rd Nov 2018
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Langerhance Cell Histiocytosis (LCH) 5 Years After B-cell Acute Lymphoblastic Leukemia in a 11 year-old boy Professor. Ansari Professor of pediatric hematology.
Presentation transcript:

Research done by Dr. Jackleen Raafat Awadallah Hanna Phd of Medical Biochemistry Researcher at Medical Biochemistry Department National Research Center Egypt Under the Supervision of Prof. Dr. Maged A. Barakat Prof. Dr. Zakaria A. El-Khayat Professor of Biochemistry Professor of Biochemistry Faculty of Pharmacy Medical Biochemistry Department Cairo University National Research Center Dr. Manal F. Ismail Ass. Professor of Biochemistry Faculty of Pharmacy Cairo University

Expression of CD 95 in Acute Lymphocytic Leukemia (ALL) in Egyptian Children before and after Treatment

Leukemia  It’s is the term used for cancer that affects the blood cells.  Marrow-based neoplasm composed predominantly of minimally or partially differentiated lymphoid precursors.

 The malignant disorder resulting from the clonal proliferation of lymphoid precursors with arrested maturation is known as  It is the most common type of Leukemia found in children that's why it is commonly called childhood leukemia.

Apoptosis (Programmed cell death)  Controlled cellular self-destruction.  Regulation of normal cell growth is balanced between cell proliferation, cell differentiation and apoptosis, a disruption of this balance is thought to be an important event leading to carcinogenesis.  Apoptosis induction is the target of most chemotheropeutic drugs.

Regulation of apoptosis  Pro- apoptotic protein. CD 95 (Fas, Apo-1)  Cross linking of Fas by its ligand (Fas L) Apoptosis

Bcl-2  It is located within the mitochondrial membrane, endoplasmic reticulum and nuclear envelope.  Bcl-2 family of proteins :- Bax, Bcl-2

Treatment protocol for childhood ALL The induction phase (6-7 weeks) The consolidation phase (8 weeks) HD-MTX, 6-MP DEX, VCR, DOX, 6-MP, ASP, Ith, MTX, Cyclo, Ara-C. VCR, DOX, Prednisone, Ara C,6-MP,Cyclo, ASP Ith (MTX, Ara C, hydrocortisone) The maintenance phase (120 weeks) Total XV (Pui et al., 2004)

ZincCopper  Zinc is found in almost every cell of the body.  It forms complexes with metalloenzymes with oxidase activity.  It stimulates the activity of approximately 100 enzymes. Nutritional status of children with ALL

Aim of the work Identify the changes occurring in newly diagnosed ALL children regarding the expression of CD 95 receptor and blood level of Bcl-2 as markers of apoptosis as well as serum zinc and copper levels prior to and during the maintenance phase of the specified treatment protocol.

Subjects Group 1 Group 3 Group 2 Ten normal healthy children Twenty five pediatric patients newly diagnosed of acute lymphocytic leukemia Twenty treated patients

Routine laboratory investigations Complete blood count (CBC) Hemoglobin concentration Bone marrow blast count Total leukocyte count Platelet count

Sampling  Determination of CD 95 % using Flowcytometer  Determination of Bcl-2 Concentration using ELISA Blood  Determination of zinc and copper levels using atomic absorption spectrophotometer Serum

 The current study demonstrated that both CD 95 % and Bcl-2 protein are useful diagnostic markers that may help not only in diagnosis but also in follow up of ALL cases.

 Long-term studies with large number of cases are still needed.  Avoiding chronic zinc deficiency should be taken into consideration in the prevention of childhood leukemia.